SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Morgan Stanley Maintains Equal-Weight on Biomarin Pharmaceutical, Lowers Price Target to $85

Morgan Stanley maintains Biomarin Pharmaceutical (NASDAQ:BMRN) with a Equal-Weight and lowers the price target from $125 to $85.

Benzinga · 08/21/2020 11:43
Morgan Stanley maintains Biomarin Pharmaceutical (NASDAQ: BMRN) with a Equal-Weight and lowers the price target from $125 to $85.